Please ensure Javascript is enabled for purposes of website accessibility

Baltimore biopharm hires neuroscience veteran Mohs as VP (access required)

Baltimore-based biopharmaceutical company AgeneBio has appointed Richard Mohs as vice president of clinical development. Mohs has more than 30 years of experience in neuroscience clinical development and led Eli Lilly's Phase 3 development team for Alzheimer's disease drug candidates solanezumab and semagacesta, AgeneBio noted in a statement Tuesday. Most recently, Mohs served as Eli Lilly's vice president ...